Cercare il medicinale per il nome

Safinamide Mesylate e Zotex

Determinazione dell'interazione di Safinamide Mesylate e Zotex e della possibilità della loro somministrazione congiunta.

Risultato di controllo:

Safinamide Mesylate <> Zotex

Rilevanza: 01.07.2022 Recensore: P.M. Shkutko, dott., in

Nella database di manuali utilizzati per creare il servizio, è stata trovata un'interazione statisticamente registrata dai risultati della ricerca, che può portare alle conseguenze negative per la salute del paziente o rafforzare un effetto positivo reciproco. È necessaria la consultazione del medico per risolvere il problema della co-somministrazione di medicinali.

Consumatore:

Utilizzando safinamide insieme con destrometorfano può aumentare il rischio di una condizione rara, ma grave chiamata sindrome serotoninergica, che possono includere sintomi quali confusione, allucinazioni, convulsioni, forti sbalzi della pressione arteriosa, aumento della frequenza cardiaca, febbre, sudorazione, brividi o tremori, visione offuscata, spasmi muscolari o rigidità, tremori, incoordinazione, crampi allo stomaco, nausea, vomito e diarrea. Il medico può essere in grado di prescrivere alternative che non interagiscono, o potrebbe essere necessario un monitoraggio più frequente di utilizzare in modo sicuro entrambi i farmaci. Parlate con il vostro medico se avete domande o dubbi. È importante informare il vostro medico su tutti gli altri farmaci in uso, tra cui le vitamine e le erbe. Non smettere di usare i farmaci senza prima parlare con il medico.

Professionista:

CONTROINDICATO: inibendo la serotonina metabolismo, inibitori della monoamino-ossidasi (Mao), compreso il selettivo delle MAO-B inibitore safinamide, può potenziare l'attività farmacologica di agenti serotoninergici come destrometorfano. Il risultato potrebbe essere un aumento del rischio di sindrome serotoninergica, che è una rara, ma grave e potenzialmente fatale condizione pensato per derivare da iperstimolazione del tronco encefalico 5-HT1A e 2A recettori. I sintomi della sindrome serotoninergica possono includere cambiamenti dello stato mentale, come irritabilità, alterazione della coscienza, confusione, allucinazioni, coma, disfunzione autonomica come tachicardia, ipertermia, sudorazione, brividi, pressione sanguigna labilità, e midriasi; anomalie neuromuscolari come iperreflessia, mioclono, tremore, rigidità, e atassia; e sintomi gastrointestinali come crampi addominali, nausea, vomito e diarrea.

GESTIONE: la somministrazione concomitante di safinamide con destrometorfano è considerato controindicato.

Fonte

Diamond S "The use of sumatriptan in patients on monoamine oxidase inhibitors." Neurology 45 (1995): 1039-40
Weiner LA, Smythe M, Cisek J "Serotonin syndrome secondary to phenelzine-venlafaxine interaction." Pharmacotherapy 18 (1998): 399-403
Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
"Product Information. Manerix (moclobemide)." Hoffmann-La Roche Limited, Mississauga, IA.
Suchowersky O, deVries JD "Interaction of fluoxetine and selegiline." Can J Psychiatry 35 (1990): 571-2
White K, Simpson G "Combined MAOI-tricyclic antidepressant treatment: a reevaluation." J Clin Psychopharmacol 1 (1981): 264-82
Fischer P "Serotonin syndrome in the elderly after antidepressive monotherapy." J Clin Psychopharmacol 15 (1995): 440-2
Feighner JP, Boyer WF, Tyler DL, Neborsky RJ "Adverse consequences of fluoxetine-MAOI combination therapy." J Clin Psychiatry 51 (1990): 222-5
Nierenberg DW, Semprebon M "The central nervous system serotonin syndrome." Clin Pharmacol Ther 53 (1993): 84-8
Graham PM, Potter JM, Paterson J "Combination monoamine oxidase inhibitor/tricyclic antidepressants interaction." Lancet 2 (1982): 440
Bem JL, Peck R "Dextromethorphan. An overview of safety issues." Drug Saf 7 (1992): 190-9
Graber MA, Hoehns TB, Perry PJ "Sertraline-phenelzine drug interaction: a serotonin syndrome reaction." Ann Pharmacother 28 (1994): 732-5
Levy AB, Bucher P, Votolato N "Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine- tryptophan combination treatment." Can J Psychiatry 30 (1985): 434-6
Phillips SD, Ringo P "Phenelzine and venlafaxine interaction." Am J Psychiatry 152 (1995): 1400-1
Martin TG "Serotonin syndrome." Ann Emerg Med 28 (1996): 520-6
Sternbach H "Danger of MAOI therapy after fluoxetine withdrawal." Lancet 2 (1988): 850-1
Sternbach H "The serotonin syndrome." Am J Psychiatry 148 (1991): 705-13
White K, Pistole T, Boyd JL "Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study." Am J Psychiatry 137 (1980): 1422-5
Klysner R, Larsen JK, Sorensen P, Hyllested M, Pedersen BD "Toxic interaction of venlafaxine and isocarboxazide." Lancet 346 (1995): 1298-9
Gillman PK "Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity." Br J Anaesth (2005):
Bhatara VS, Bandettini FC "Possible interaction between sertraline and tranylcypromine." Clin Pharm 12 (1993): 222-5
"Product Information. Cymbalta (duloxetine)." Lilly, Eli and Company, Indianapolis, IN.
"Product Information. Fetzima (levomilnacipran)." Forest Pharmaceuticals, St. Louis, MO.
Alvine G, Black DW, Tsuang D "Case of delirium secondary to phenelzine/L-tryptophan combination." J Clin Psychiatry 51 (1990): 311
Cerner Multum, Inc. "Australian Product Information." O 0
Brubacher JR, Hoffman RS, Lurin MJ "Serotonin syndrome from venlafaxine-tranylcypromine interaction." Vet Hum Toxicol 38 (1996): 358-61
Bodner RA, Lynch T, Lewis L, Kahn D "Serotonin syndrome." Neurology 45 (1995): 219-23
Beasley CM Jr, Masica DN, Heiligenstein JH, Wheadon DE, Zerbe RL "Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings." J Clin Psychopharmacol 13 (1993): 312-20
Rivers N, Horner B "Possible lethal reaction between nardil and dextromethorphan." Can Med Assoc J 103 (1970): 85
"Product Information. Effexor (venlafaxine)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
Cetaruk EW, Aaron CK "Hazards of nonprescription medications." Emerg Med Clin North Am 12 (1994): 483-510
Chan BSH, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG "Serotonin syndrome resulting from drug interactions." Med J Aust 169 (1998): 523-5
"Product Information. Viibryd (vilazodone)." Trovis Pharmaceuticals LLC, New Haven, CT.
De Vita VT, Hahn MA, Oliverio VT "Monoamine oxidase inhibition by a new carcinostatic agent, n-isopropyl-a-(2-methylhydrazino)-p-toluamide (MIH). (30590)." Proc Soc Exp Biol Med 120 (1965): 561-5
Schulz R, Antonin KH, Hoffmann E, et al "Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline." Clin Pharmacol Ther 46 (1989): 528-36
Mills KC "Serotonin syndrome: A clinical update." Crit Care Clin 13 (1997): 763
"Product Information. D.H.E. 45 (dihydroergotamine)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
Graham PM, Ilett KF "Danger of MAOI therapy after fluoxetine withdrawal." Lancet 2 (1988): 1255-6
Pope HG Jr, Jonas JM, Hudson JI, Kafka MP "Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan." Am J Psychiatry 142 (1985): 491-2
Mathew NT, Tietjen GE, Lucker C "Serotonin syndrome complicating migraine pharmacotherapy." Cephalalgia 16 (1996): 323-7
Brannan SK, Talley BJ, Bowden CL "Sertraline and isocarboxazid cause a serotonin syndrome." J Clin Psychopharmacol 14 (1994): 144-5
Thomas JM, Rubin EH "Case report of a toxic reaction from a combination of tryptophan and phenelzine." Am J Psychiatry 141 (1984): 281-3
Corkeron MA "Serotonin syndrome - a potentially fatal complication of antidepressant therapy." Med J Aust 163 (1995): 481-2
Jacob JE, Wagner ML, Sage JI "Safety of selegiline with cold medications." Ann Pharmacother 37 (2003): 438-41
Spiker DG, Pugh DD "Combining tricyclic and monoamine oxidase inhibitor antidepressants." Arch Gen Psychiatry 33 (1976): 828-30
"Product Information. Pristiq (desvenlafaxine)." Wyeth Laboratories, Philadelphia, PA.
"Product Information. Savella (milnacipran)." Forest Pharmaceuticals, St. Louis, MO.
Sovner R, Wolfe J "Interaction between dextromethorphan and monoamine oxidase inhibitor therapy with isocarboxazid ." N Engl J Med 319 (1988): 1671
Heisler MA, Guidry JR, Arnecke B "Serotonin syndrome induced by administration of venlafaxine and phenelzine." Ann Pharmacother 30 (1996): 84
Staufenberg EF, Tantam D "Malignant hyperpyrexia syndrome in combined treatment." Br J Psychiatry 154 (1989): 577-8
Darcy PF, Griffin JP "Interactions with drugs used in the treatment of depressive illness." Adverse Drug React Toxicol Rev 14 (1995): 211-31
Jimenez-Genchi A "Immediate switching from moclobemide to duloxetine may induce serotonin syndrome." J Clin Psychiatry 67 (2006): 1821-1822
"Product Information. Xadago (safinamide)." US WorldMeds LLC, Louisville , KY.
Diamond S, Pepper BJ, Diamond ML, Freitag FG, Urban GJ, Erdemoglu AK "Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports." Neurology 51 (1998): 274-6
Gardner DM, Lynd LD "Sumatriptan contraindications and the serotonin syndrome." Ann Pharmacother 32 (1998): 33-8
Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11
Pettinger WA, Soyangco FG, Oates JA "Inhibition of monoamine oxidase in man by furazolidone." Clin Pharmacol Ther 9 (1968): 442-7

Safinamide Mesylate

Nome generico: safinamide

Marchio commerciale: Xadago

Sinonimo: Safinamide

Cos`è Safinamide Mesylate?

Zotex

Nome generico: dextromethorphan / guaifenesin / phenylephrine

Marchio commerciale: Tussidex, Zotex, Broncotron-D, Duravent DM, Giltuss, Mucinex Fast-Max Severe Congestion & Cough, Phlemex Forte, Robitussin Children's Cough & Cold CF, Robitussin Multi-Symptom Cold, Tusicof, Tussin CF, Vanacof DM, Z-tuss DM, Deconex DMX, Maxiphen DM, Tussex, Tussafed-EX, Sinutuss DM, GDP-EX, Duraphen DM, TriTuss, TriTuss-ER, Tussafed-EX Drops, Certuss-D, Dacex-PE, Anextuss, Dexcon-PE, Zotex LAX, Dacex-DM, Dexcon-DM, Duraphen II DM, Duraphen Forte, G-Phen DM, Despec DM Syrup, Phlemex-PE, Guaphen Forte, Guaphen II DM, Z-Dex, Aquatab C, Robafen CF, DuraMAX, Tusso-XR, Tusso-DM, Robitussin Cough & Cold CF, Ambi 40/1000/60, Maxiphen-G DM, Robitussin Pediatric Cough & Cold CF, Deconex DM, PDM GG, ExeTuss-DM, Endacon DM, Giltuss TR, Q-Tussin CF, Tusso-DMR, Execof ER, Dynatuss EX, Robitussin Cough & Cold CF To Go, Zotex-EX, Endacon, Robitussin Cough & Cold CF Max, Mucinex Children's Multi-Symptom Cold, Supress-DX, Tussi-Pres, Tussi-Pres Pediatric, Pres Gen Pediatric, Pres Gen, Robitussin Peak Cold Max Strenth Multi-S, G-Tusicof, Adult Severe Congestion & Cough, Giltuss Pediatrics, Desgen DM, G-Supress DX, Tusslin, Desgen Pediatric, G-Tron Ped, Broncotron Ped, Tusslin Pediatric, Nivanex DMX, Relhist DMX, Giltuss Cough & Cold, Children Giltuss Cough & Cold, VanaTab DM, Tukol Cough & Cold, Robitussin Peak Cold Multi-Sympton Cold, Deconex DMX Poly

Sinonimo: non c`è

Cos`è Zotex?

+ Aggiungere un medicinale Eliminare tutto

In corso di controllo compatibilità e interazioni farmacologiche vengono utilizzati i dati presi dalle fonti: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Elenco interazioni popolari